HAARP Logo HIV / AIDS Asia Regional Program

An inclusive response to drug use related harm

Toolbar Navigation

  • Skip to main content
  • Resize font

Search

Main Navigation

  • Regional Program
    • About HAARP
    • HCCF
    • Managing HAARP
    • Program Background
  • Country Programs
  • Advocacy
    • Objectives
    • Approach
  • Gender
    • Situation Analysis
    • Goal & Objectives
    • Gender Principles
  • Evaluating Ourselves
    • HMRG
    • Four Stages
    • Principles
  • Resources
    • Keyword Search
    • Advanced Search
    • Acronyms
    • Links
    • Travel Tips
  • News & Events
    • News
    • Events
    • HAARP Quarterly Newsletter
    • For the Media

Sub Navigation

Country Programs

  • Expected Outcomes
  • ARHP and HAARP Countries
  • RTCU's role at the country level
  • Burma (Myanmar)
    • Context and Situation Analysis
    • Country Flexible Program
  • Cambodia
  • China
  • Laos
  • Philippines
  • Vietnam

 

 

 

 

Breadcrumb Navigation

You are here:

  1. Home
  2. Country Programs
  3. Burma (Myanmar)

Burma (Myanmar)

This section contains an expanded situation analysis, and details about the Burma (Myanmar) Country Flexible Prorgam. Shooting Gallery. Source:Jimmy Dorabjee/Burnet CHR
Shooting Gallery. Source:Jimmy Dorabjee/Burnet CHR

Burma (Myanmar) is located in South-eastern Asia and borders China, India and Thailand. Burma (Myanmar) is the world's second largest producer of illicit opium and one of the largest producers of Amphetamine Type Stimulants (ATS).

In Burma (Myanmar), heroin use predominates in the northern states (Kachin and Shan) and in major cities, while opium use is more common in the Eastern and Southern states. As opium becomes less available in Burma (Myanmar), there is a shift towards the injection of heroin and use of ATS.

Reports from the Central Committee on Drug use Control suggest that drug use is a male phenomenon. However, recent situational assessments indicate that there is a growing number of female drug users who are particularly vulnerable due to stigma and discrimination and lack of access to services.

The greatest risk associated with IDU in Burma (Myanmar) is HIV. About 30 per cent of all people living with HIV in Burma (Myanmar) have histories of injecting drugs. It is estimated that about 50-90 per cent of all injecting drug users (IDUs) have HIV.

Furthermore, needle-sharing is the norm. Factors such as poor access to clean needles - possession of needle and syringes is illegal, and poor knowledge about HIV leads many IDUs to share their injecting equipment. High HIV prevalence among IDUs, coupled with high mobility, high imprisonment rates and needle-sharing results in explosive epidemics and requires immediate, targeted interventions.

The National Strategic Plan on HIV/AIDS 2006-2010 places a high priority on prevention among key populations at higher risk of HIV including drug users. An operational plan (2006-2009) with specific targets has been developed to guide the implementation of the national strategy.

Although harm reduction programs are operating in Burma (Myanmar), there is a need to establish new initiatives and strengthen existing ones.

  Map of Burma (Myanmar). Source: Google Maps
Map of Burma (Myanmar). Source: Google Maps

Related Resources

  • Service Coverage for HIV and AIDS, Myanmar (PDF)
  • Prevention and Treatment of HIV in Myanmar (PDF)
  • Progress of HIV Epidemic in Myanmar 2007 (PDF)
  • HIV/AIDS and Drug Use in Myanmar (PDF)
  • Epidemiological Factsheet on HIV/AIDS and STIs - Myanmar (PDF)
  • Myanmar Strategic Programme Framework - Draft 2004-2007 (PDF)
  • Joint Programme for HIV/AIDS in Myanmar - Progress Report 2003-2004 (PDF)
  • Media Fact Sheet - UNAIDS Myanmar Country Office (PDF)
  • Opium Poppy Cultivation in the Golden Triangle Laos, Myanmar, Thailand (PDF)
  • AIDS Epidemic Update 2007 (PDF)
  • 2007 World Drug Report (PDF)
  • UNAIDS Terminology Guide (PDF)
  • Patterns and trends of amphetamine-type substances and other drugs od abuse in East Asia and the Pacific 2006 (PDF)
  • Situational analysis of illicit drug issues & responses in the Asia-Pacific region (PDF)
  • Map Report 2005 (PDF)

useful Links

  • UNAIDS in Burma (Myanmar)
  • WHO in Burma (Myanmar)
  • UNODC in Burma (Myanmar)

 

Recommended Resources

  • 'Out of the Margin' - Dutch Policy on Harm Reduction
  • Human Rights and Drug Control - Beckley Foundation
  • UN Secretary General on Criminalisation
  • HIV Prevention Programming Guidelines by UNAIDS
  • AusAID Gender Policy

 

Subscribe

To select HAARP news mailing lists please enter your email and submit.

   

Program Information

HIV / AIDS Asia Regional Program

Client Information

An Australian Government, AusAID initiative
Copyright © HLSP 2008 - a member of the Mott MacDonald Group

Toolbar Navigation

  • Sitemap
  • Legal
  • Accessibility
  • Contact